Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

1
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
1
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

13
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
13
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

4.2K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
4.2K
Anatomy of the Adrenal Glands01:17

Anatomy of the Adrenal Glands

6.5K
The adrenal or supra-renal glands, situated above the kidneys and aligned with the twelfth rib, are paired pyramid-shaped structures crucial for the body's stress response. During stress, these glands secrete hormones vital for adaptive physiological reactions.
These glands possess a distinctive yellow tinge due to the stored cholesterol and fatty acids required for hormone synthesis. They are encased in a fibrous capsule and cushioned by fat.
The adrenal gland comprises two distinct...
6.5K
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

7.0K
Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
7.0K
Sympathetic Pathways: Collateral Ganglia and Adrenal Medulla01:27

Sympathetic Pathways: Collateral Ganglia and Adrenal Medulla

3.5K
The sympathetic pathways of the collateral ganglia and adrenal medulla serve unique but interconnected roles in the sympathetic response.
Collateral Ganglia
Sympathetic preganglionic axons reach the collateral ganglia along the route of splanchnic nerves. These nerves bypass the sympathetic trunk and communicate with sympathetic postganglionic neurons housed in the prevertebral ganglia. These ganglia supply the organs of the abdominopelvic cavity.
The greater splanchnic nerve, formed by the...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term cabergoline use does not predict degree of prolactinoma fibrosis nor significantly impact surgical outcomes.

Pituitary·2026
Same author

Editorial: Advances and challenges in adult-onset craniopharyngioma.

Frontiers in endocrinology·2025
Same author

Management of Recurrent and Aggressive Non-Functioning Pituitary Adenomas.

Journal of clinical medicine·2025
Same author

Posterior pituitary tumors: an entity unto itself.

Pituitary·2025
Same author

Growth Hormone Replacement in Craniopharyngioma: Analysis of the Hypopituitary Control and Complications Study (HypoCCS).

Journal of the Endocrine Society·2025
Same author

Immune Checkpoint Inhibitor Therapy for Aggressive Pituitary Neuroendocrine Tumors.

The Journal of clinical endocrinology and metabolism·2025

Related Experiment Video

Updated: Apr 19, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

20.2K

Silent corticotroph adenomas.

Odelia Cooper1

  • 1Pituitary Center, Cedars-Sinai Medical Center, 127 S. San Vicente Blvd., Suite A6600, Los Angeles, CA, 90048, USA, coopero@cshs.org.

Pituitary
|December 24, 2014
PubMed
Summary

Silent corticotroph adenomas (SCAs) are often diagnosed late and may recur frequently. Rigorous monitoring for recurrence and hypopituitarism is essential for patients with SCAs.

Area of Science:

  • Endocrinology
  • Neurosurgery
  • Oncology

Background:

  • Silent corticotroph adenomas (SCAs) are a subtype of pituitary adenomas.
  • SCAs are often diagnosed incidentally after surgery for presumed nonfunctioning adenomas (NFAs).
  • SCAs do not present with clinical or biochemical hypercortisolism.

Purpose of the Study:

  • To review the incidence, pathogenesis, and clinical behavior of SCAs.
  • To highlight the diagnostic challenges and management of SCAs.
  • To emphasize the importance of postoperative monitoring for SCAs.

Main Methods:

  • Systematic literature review using PubMed.
  • Analysis of epidemiological data.
  • Review of clinical presentation and management strategies.

More Related Videos

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

24.6K
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
09:53

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on: July 5, 2021

4.4K

Related Experiment Videos

Last Updated: Apr 19, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

20.2K
A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

24.6K
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
09:53

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on: July 5, 2021

4.4K

Main Results:

  • SCAs represent 20% of corticotroph adenomas and 3-19% of NFAs.
  • SCAs share preoperative features with NFAs but may show increased cavernous sinus invasion.
  • Patients with SCAs experience more frequent and earlier recurrences than those with NFAs.

Conclusions:

  • SCAs require vigilant postoperative surveillance for recurrence.
  • Monitoring for hypopituitarism is crucial in patients with SCAs.
  • SCAs may necessitate multidisciplinary treatment approaches.